About this document

Wockhardt by Sanil Jagiwala is a document available to read on EtoBox.

Wockhardt has developed MIQNAF®, a next-generation macrolide antibiotic for community-acquired bacterial pneumonia (CABP), which demonstrates efficacy comparable to the gold standard Moxifloxacin in just three days of treatment. Clinical trials showed a high cure rate against various pathogens, including antibiotic-resistant strains, with a favorable safety profile. This innovation marks a significant advancement in antibiotic development, providing a shorter treatment duration and improved patient complian

Author

Sanil Jagiwala

Language

EN